Key facts
- Notable investors include InnoMed Capital, JYTH Investment Management, Nanchuang Research Institute.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Dingshi Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Dingshi Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Dingshi Biotechnology
Providers of genetic diagnosis and treatment services in the field of medical research. The company is mainly engaged in medical research and experimental development, human gene diagnosis and treatment technology development, cell technology research and development and application, providing clients with scientific research and technical services.
- Sector
- Healthcare
- HQ
- Nanjing, China
- Founded
- 2023
- Ownership
- Privately Held (backing)
Dingshi Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Dingshi Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Dingshi Biotechnology in its N-PORT filings yet. We sweep new filings monthly.